| Mitchell Jablons, MD | |
|
33 Overlook Rd, Ste 311, Summit, NJ 07901-3570 | |
| (908) 598-1500 | |
| Not Available |
| Full Name | Mitchell Jablons |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 51 Years |
| Location | 33 Overlook Rd, Summit, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164483418 | NPI | - | NPPES |
| 0381209 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 25MA04398100 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summit Medical Group Pa | 5395642276 | 1253 |
News Archive
A new study by researchers at the University of Southern California suggests that some TV may be good for you. Researchers found that a storyline on the primetime NBC network drama ER that dealt with teen obesity, hypertension and healthy eating habits had a positive impact on the attitudes and behaviors of viewers, particularly among men.
Medivation, Inc. and Astellas Pharma Inc. today announced treatment of the first patient in a second Phase 3 clinical trial of the investigational drug MDV3100, which expands the Phase 3 development of the novel, triple-acting oral androgen receptor antagonist into an earlier-stage patient population. Known as PREVAIL, the trial will evaluate MDV3100 in men with advanced prostate cancer who have not yet received chemotherapy. Initiation of the PREVAIL trial triggers a milestone payment to Medivation under its collaboration agreement with Astellas.
Single atom quantum dots created by researchers at Canada's National Institute for Nanotechnology and the University of Alberta make possible a new level of control over individual electrons, a development that suddenly brings quantum dot-based devices within reach.
Osteoporosis is a disease in which bone loses mass as a result of age or other influences. This weakening is the leading cause of fractures in the elderly, often after trivial injuries, and makes treating these "pathological fractures" a challenge.
› Verified 4 days ago
| Entity Name | Summit Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942254347 PECOS PAC ID: 5395642276 Enrollment ID: O20031218000011 |
News Archive
A new study by researchers at the University of Southern California suggests that some TV may be good for you. Researchers found that a storyline on the primetime NBC network drama ER that dealt with teen obesity, hypertension and healthy eating habits had a positive impact on the attitudes and behaviors of viewers, particularly among men.
Medivation, Inc. and Astellas Pharma Inc. today announced treatment of the first patient in a second Phase 3 clinical trial of the investigational drug MDV3100, which expands the Phase 3 development of the novel, triple-acting oral androgen receptor antagonist into an earlier-stage patient population. Known as PREVAIL, the trial will evaluate MDV3100 in men with advanced prostate cancer who have not yet received chemotherapy. Initiation of the PREVAIL trial triggers a milestone payment to Medivation under its collaboration agreement with Astellas.
Single atom quantum dots created by researchers at Canada's National Institute for Nanotechnology and the University of Alberta make possible a new level of control over individual electrons, a development that suddenly brings quantum dot-based devices within reach.
Osteoporosis is a disease in which bone loses mass as a result of age or other influences. This weakening is the leading cause of fractures in the elderly, often after trivial injuries, and makes treating these "pathological fractures" a challenge.
› Verified 4 days ago
| Entity Name | American Anesthesiology Of New Jersey Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386654036 PECOS PAC ID: 0042112500 Enrollment ID: O20040123001039 |
News Archive
A new study by researchers at the University of Southern California suggests that some TV may be good for you. Researchers found that a storyline on the primetime NBC network drama ER that dealt with teen obesity, hypertension and healthy eating habits had a positive impact on the attitudes and behaviors of viewers, particularly among men.
Medivation, Inc. and Astellas Pharma Inc. today announced treatment of the first patient in a second Phase 3 clinical trial of the investigational drug MDV3100, which expands the Phase 3 development of the novel, triple-acting oral androgen receptor antagonist into an earlier-stage patient population. Known as PREVAIL, the trial will evaluate MDV3100 in men with advanced prostate cancer who have not yet received chemotherapy. Initiation of the PREVAIL trial triggers a milestone payment to Medivation under its collaboration agreement with Astellas.
Single atom quantum dots created by researchers at Canada's National Institute for Nanotechnology and the University of Alberta make possible a new level of control over individual electrons, a development that suddenly brings quantum dot-based devices within reach.
Osteoporosis is a disease in which bone loses mass as a result of age or other influences. This weakening is the leading cause of fractures in the elderly, often after trivial injuries, and makes treating these "pathological fractures" a challenge.
› Verified 4 days ago
| Entity Name | Ny Nj Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396299582 PECOS PAC ID: 9537447677 Enrollment ID: O20161025001805 |
News Archive
A new study by researchers at the University of Southern California suggests that some TV may be good for you. Researchers found that a storyline on the primetime NBC network drama ER that dealt with teen obesity, hypertension and healthy eating habits had a positive impact on the attitudes and behaviors of viewers, particularly among men.
Medivation, Inc. and Astellas Pharma Inc. today announced treatment of the first patient in a second Phase 3 clinical trial of the investigational drug MDV3100, which expands the Phase 3 development of the novel, triple-acting oral androgen receptor antagonist into an earlier-stage patient population. Known as PREVAIL, the trial will evaluate MDV3100 in men with advanced prostate cancer who have not yet received chemotherapy. Initiation of the PREVAIL trial triggers a milestone payment to Medivation under its collaboration agreement with Astellas.
Single atom quantum dots created by researchers at Canada's National Institute for Nanotechnology and the University of Alberta make possible a new level of control over individual electrons, a development that suddenly brings quantum dot-based devices within reach.
Osteoporosis is a disease in which bone loses mass as a result of age or other influences. This weakening is the leading cause of fractures in the elderly, often after trivial injuries, and makes treating these "pathological fractures" a challenge.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mitchell Jablons, MD Po Box 48078, Newark, NJ 07101-4878 Ph: () - | Mitchell Jablons, MD 33 Overlook Rd, Ste 311, Summit, NJ 07901-3570 Ph: (908) 598-1500 |
News Archive
A new study by researchers at the University of Southern California suggests that some TV may be good for you. Researchers found that a storyline on the primetime NBC network drama ER that dealt with teen obesity, hypertension and healthy eating habits had a positive impact on the attitudes and behaviors of viewers, particularly among men.
Medivation, Inc. and Astellas Pharma Inc. today announced treatment of the first patient in a second Phase 3 clinical trial of the investigational drug MDV3100, which expands the Phase 3 development of the novel, triple-acting oral androgen receptor antagonist into an earlier-stage patient population. Known as PREVAIL, the trial will evaluate MDV3100 in men with advanced prostate cancer who have not yet received chemotherapy. Initiation of the PREVAIL trial triggers a milestone payment to Medivation under its collaboration agreement with Astellas.
Single atom quantum dots created by researchers at Canada's National Institute for Nanotechnology and the University of Alberta make possible a new level of control over individual electrons, a development that suddenly brings quantum dot-based devices within reach.
Osteoporosis is a disease in which bone loses mass as a result of age or other influences. This weakening is the leading cause of fractures in the elderly, often after trivial injuries, and makes treating these "pathological fractures" a challenge.
› Verified 4 days ago
Chang Kweon, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 33 Overlook Rd, Ste 311, Summit, NJ 07901 Phone: 908-598-1500 | |
Jason Byers, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 33 Overlook Rd, Ste 311, Summit, NJ 07901 Phone: 908-598-1500 | |
Dr. Dmitry Rozin, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-2000 | |
Kathleen M Boreale, NP Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 11 Overlook Road, Suite B110, Summit, NJ 07901 Phone: 908-522-2709 | |
Ryan Edward Boyne, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 516-945-3000 | |
Carol E Zimmermann, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 33 Overlook Rd, Ste 311, Summit, NJ 07901 Phone: 908-598-1500 | |
Shekhar C. Karmaker, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 33 Overlook Rd, Suite 311, Summit, NJ 07901 Phone: 908-944-5204 |